Research

Cellular

Modern systematic evidence assessment and economic appraisal favour the use of lipid-lowering drugs especially statins at higher doses than currently prescribed in secondary prevention.

Healthcare practitioners should consider prescribing higher doses of statins for patients in secondary prevention.

StrongSupportsmedium confidence
Modern systematic evidence assessment and economic appraisal convincingly favour the use of lipid-lowering drugs especially statins at higher doses than currently prescribed in secondary prevention.
Nadeem Qureshi et al. · Current Opinion in Lipidology · 2015

Why this rating

The claim is based on systematic evidence assessment and economic appraisal.

Source

Prioritizing health outcomes in a limited world

Nadeem Qureshi et al. · Current Opinion in Lipidology · 2015

DOI 10.1097/mol.0000000000000170

reviewCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →